Partner Gabor Garai was quoted in an article that appeared in the Boston Globe on May 10, 2013 titled, “Markets draw life science start-ups.” The article discussed how rebounding financial markets are attracting an increasing number of life sciences start-ups looking to raise large amounts of money through IPOs — resulting in the anticipated biggest coming-out class for life sciences since 2007. The article highlighted the risks to going public, but noted that public offerings are emerging as the financing event of choice for start-ups that do not want to give up too much control to private investors or larger industry players. Mr. Garai was quoted as saying, “When it comes to drugs, the cost of getting anything to market has become inordinate. Right now, there’s more money in the public markets chasing deals than in the venture capital markets. We’re seeing the first signs of spring after a cold winter for IPOs.”
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"